Biobank for Bipolar Disorder
Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder
The purpose of this study is to establish a bipolar disorder biobank with genetic data from 4000 people with Bipolar I Disorder (BDI), Bipolar II Disorder (BDII), and Schizoaffective Disorder, Bipolar Type (SA-BD) for use in genomic disease risk studies and pharmogenomic studies.
What will happen if I decide to participate?
The study includes a clinical interview and a blood draw. Participants will be compensated $50 for their time and contributions.
Who can participate?
You may be eligible to participate in a University of Minnesota research study on the genetics of bipolar disorder if you:
- Are between the ages of 18 and 80
- Have been diagnosed with Bipolar I Disorder (BDI), or Bipolar II Disorder (BDII), or Schizoaffective Disorder, Bipolar Type (SA-BD)
For more information:
Tegan Carr, study coordinator